Kursk Regional Clinical Oncology Center
Kursk, Russian Federation
Cancer treatment center in Russia
х, Елисеева, 1, Kislino, Kursk Oblast, 305016
About Kursk Regional Clinical Oncology Center
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Kursk Regional Clinical Oncology Center
During the past decade, Kursk Regional Clinical Oncology Center conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of NeuVax™ (Nelipepimut-S or E75) Vaccine to Prevent Breast Cancer Recurrence
2011-11-01
2016-09-21
Completed
758
Proof-of-Concept Study in Cancer Patients to Assess Efficacy of Elsiglutide in Preventing Chemotherapy-Induced Diarrhea
2012-02-01
2013-10-01
Completed
138
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
2018-10-16
2022-01-20
Completed
807
Clinical Trials Sponsors and Collaborators
Clinical Trials Conditions at Kursk Regional Clinical Oncology Center
According to Clinical.Site data, the most researched conditions in "Kursk Regional Clinical Oncology Center" are
"Breast Cancer" (1 trials), "Breast Cancer With Low to Intermediate HER2 Expression" (1 trials) and "Diarrhea" (1 trials). Many other conditions were trialed in "Kursk Regional Clinical Oncology Center" in a lesser frequency.
Clinical Trials Intervention Types at Kursk Regional Clinical Oncology Center
Most popular intervention types in "Kursk Regional Clinical Oncology Center" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.
The name of intervention was led by "EG12014" (1 trials), "Elsiglutide" (1 trials), "Herceptin" (1 trials), "Leukine® (sargramostim, GM-CSF) and water for injection" (1 trials) and "NeuVax™ vaccine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Kursk Regional Clinical Oncology Center
The vast majority of trials in "Kursk Regional Clinical Oncology Center" are
2 trials for "Female" genders and 1 trials for "All" genders.
Clinical Trials Status at Kursk Regional Clinical Oncology Center
Currently, there are NaN active trials in "Kursk Regional Clinical Oncology Center".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 3 completed trials in Kursk Regional Clinical Oncology Center,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Kursk Regional Clinical Oncology Center, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 2 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".